Unrecognised myocardial infarction in subjects at high vascular risk: prevalence and determinants

Objective: To investigate the prevalence and determinants of unrecognised myocardial infarction (UMI). Design, setting, patients: In this cross-sectional study in a tertiary centre, a delayed enhancement cardiac MRI (DE-CMR), which identifies both Q-wave and non-Q wave MIs, was performed in 502 subjects with manifest extracardiac atherosclerotic disease or marked risk factors for atherosclerosis without symptomatic coronary artery disease. Main outcome measures: UMI was defined as the presence of delayed enhancement without corresponding clinical history. Results: DE-CMR was of sufficient image quality in 480 (95.6%) subjects. A UMI was present in 45 (9.4%) of all subjects; in 13.1% of men and in 3.7% of women. The risk of UMI increased from 6.0% (95% CI 2.2 to 9.8%) in those with two vascular risk factors up to 26.2% (95% CI 15.2 to 37.3%) in those with four or five risk factors. In a multivariable analysis, the risk of UMI was related to male gender (OR 2.3 (95% CI 1.0 to 5.6)), age (OR 1.04 (95% CI 1.00 to 1.07) per year), ever smoking (OR 3.1 (95% CI 1.0 to 9.1), history of stroke (OR 1.9 (95% CI 0.8 to 4.3)) and history of aneurysm of the abdominal aorta (OR 2.6 (95% CI 1.0 to 6.9)). Conclusions: In cardiac asymptomatic subjects at high vascular risk, UMI is common. The risk of UMI increases with increasing presence of risk factors.

[1]  P. Wilson,et al.  Prediction of cardiovascular disease events. , 2011, Cardiology clinics.

[2]  W. Mali,et al.  Differences in determinants of left ventricular mass assessed by cardiac magnetic resonance imaging across subjects with and without previous symptomatic atherosclerotic disease. , 2010, International journal of cardiology.

[3]  O. Jolobe Unrecognised myocardial infarction in subjects at high vascular risk , 2009, Heart.

[4]  Salim Yusuf,et al.  Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. , 2009, American heart journal.

[5]  A. Einstein Radiation risk from coronary artery disease imaging: how do different diagnostic tests compare? , 2008, Heart.

[6]  M. Hamon,et al.  Should radial artery access be the “gold standard” for PCI? , 2008, Heart.

[7]  R. Barriales-Villa,et al.  [Pheochromocytoma-related cardiomyopathy or stress cardiomyopathy secondary to pheochromocytoma: is new terminology needed?]. , 2008, Revista espanola de cardiologia.

[8]  S. Capewell,et al.  Maximising secondary prevention therapies in patients with coronary heart disease , 2007, Heart.

[9]  Yuh-Min Song,et al.  Faculty Opinions recommendation of Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. , 2007 .

[10]  Jeroen J. Bax,et al.  The prevalence and prognosis of unrecognized myocardial infarction and silent myocardial ischemia in patients undergoing major vascular surgery , 2007, Coronary artery disease.

[11]  Lars Lind,et al.  Clinically unrecognized myocardial infarction detected at MR imaging may not be associated with atherosclerosis. , 2007, Radiology.

[12]  G. Feder,et al.  Secondary prevention for patients following a myocardial infarction: summary of NICE guidance , 2007, Heart.

[13]  D. Cook,et al.  Trends in secondary prevention of ischaemic heart disease in the UK 1994–2005: use of individual and combination treatment , 2007, Heart.

[14]  M. Bouvy,et al.  Effect of drug combinations on admission for recurrent myocardial infarction , 2007, Heart.

[15]  Y. Graaf,et al.  Rationale and design of the SMART Heart study A prediction model for left ventricular hypertrophy in hypertension , 2007 .

[16]  W. Mali,et al.  Rationale and design of the SMART Heart study , 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[17]  W. Mali,et al.  Left ventricular hypertrophy: a shift in paradigm. , 2007, Current medicinal chemistry.

[18]  Håkan Ahlström,et al.  Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. , 2006, Journal of the American College of Cardiology.

[19]  Roger B. Davis,et al.  Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.

[20]  J. Sobrino,et al.  Pheochromocytoma-Related Cardiomyopathy , 2006 .

[21]  N. Geller,et al.  Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. , 2006, Journal of the American College of Cardiology.

[22]  J. Christiansen,et al.  Detection of myocardial scar by contrast-enhanced cardiac magnetic resonance imaging in patients with troponin-positive chest pain and minimal angiographic coronary artery disease. , 2006, The American journal of cardiology.

[23]  A. Hofman,et al.  Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. , 2006, European heart journal.

[24]  H. Lange,et al.  Randomized comparison of operator radiation exposure during coronary angiography and intervention by radial or femoral approach , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[25]  N. Wareham,et al.  What is the evidence that microalbuminuria is a predictor of cardiovascular disease events , 2005 .

[26]  N. Wareham,et al.  What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? , 2005, Current opinion in nephrology and hypertension.

[27]  J. Debatin,et al.  Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. , 2005, AJR. American journal of roentgenology.

[28]  A. Hofman,et al.  The association of Rose questionnaire angina pectoris and coronary calcification in a general population: the Rotterdam Coronary Calcification Study. , 2004, Annals of epidemiology.

[29]  A. Algra,et al.  Second Manifestations of ARTerial disease (SMART) study: Rationale and design , 1999, European Journal of Epidemiology.

[30]  Abnash C. Jain,et al.  Etiologies of left bundle branch block and correlations with hemodynamic and angiographic findings. , 2003, The American journal of cardiology.

[31]  Edwin Wu,et al.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.

[32]  A. Go,et al.  Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain , 2000 .

[33]  B. Gersh,et al.  Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. , 2000, Journal of the American College of Cardiology.

[34]  W. Young,et al.  Reversible catecholamine-induced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[35]  L. S. Jónsdóttir,et al.  Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. , 1998, European heart journal.

[36]  A. Hoes,et al.  Prevalence, Determinants, and Misclassification of Myocardial Infarction in the Elderly , 1997, Epidemiology.

[37]  R. Kim,et al.  Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.

[38]  G. Thorgeirsson,et al.  Unrecognized Myocardial Infarction: Epidemiology, Clinical Characteristics, and the Prognostic Role of Angina Pectoris: The Reykjavik Study , 1995, Annals of Internal Medicine.

[39]  W. L. Ooi,et al.  Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. , 1990, The American journal of cardiology.

[40]  D. Spodick,et al.  The incidence and prognosis of unrecognized myocardial infarction. , 1990, Archives of internal medicine.

[41]  W. Kannel,et al.  Incidence, precursors and prognosis of unrecognized myocardial infarction. , 1990, Advances in cardiology.

[42]  K. Yano,et al.  The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program. , 1989, Archives of internal medicine.

[43]  J. Neaton,et al.  Unrecognized myocardial infarction: experience in the multiple risk factor intervention trial (MRFIT) , 1987, Circulation.

[44]  W. Kannel,et al.  Prognosis after initial myocardial infarction: the Framingham study. , 1979, The American journal of cardiology.

[45]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[46]  J. Medalie,et al.  Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. , 1976, Annals of internal medicine.

[47]  C. Jenkins,et al.  Clinically unrecognized myocardial infarction in the Western Collaborative Group Study. , 1967, The American journal of cardiology.

[48]  R. Magno,et al.  Coronary heart disease , 1957 .